Cell survival signaling during apoptosis: Implications in drug resistance and anti-cancer therapeutic development

Progress in Drug Research

Volumn 63, Issue , 2005, Pages 115-145

  Choy, Grace ^a   Liu, Jun Wei ^a   Chandra, Dhyan ^a   Tang, Dean G ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Apoptosis; FOXO3a; NF B; ROS; Stress; Survival

Indexed keywords

ANTINEOPLASTIC AGENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; PROTEIN P21; TRANSCRIPTION FACTOR;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER CELL; CANCER CHEMOTHERAPY; CELL SURVIVAL; DRUG DESIGN; DRUG SENSITIVITY; GENE ACTIVATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

EID: 26044448679     PISSN: 0071786X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/3-7643-7414-4_6     Document Type: Review

References (175)

1. Wang E, Marcotte R, Petroulakis E (1999) Signaling pathways for apoptosis: A race-track for life and death. J Cell Biochem Suppl 32/33: 95-102
2. Sprick MR, Walczak H (2004) The interplay between the Bcl-2 family and death receptor-mediated apoptosis. Biochim Biophys Acta 1644: 125-132
3. Wang J, Lenardo MJ (2000) Role of caspases in apoptosis, development, and cytokine maturation revealed by homozygous gene deficiencies. J Cell Sci 113: 753-757
4. Salveson GS (2002) Caspases and apoptosis. Essays Biochem 38: 9-19
5. Gruss HJ, Dower SK (1995) Involvement in the pathology of malignant lymphomas. Blood 85: 3378-3404
6. Baker SJ, Reddy EP (1998) Modulation of life and death by the TNF receptor superfamily. Oncogene 17: 3261-3270
7. Fulda S, Debatin KM (2004) Signaling through death receptors in cancer therapy. Curr Opin Pharmacol 4: 327-332
8. Chang DW, Ditsworth D, Liu H, Srinivasula SM, Alnemri ES, Yang X (2003) Oligomerization is a general mechanism for the activation of initiator and inflammatory procaspases. J Biol Chem 278: 16466-16469
9. Chen M, Oroszo A, Spencer DM, Wang J (2002) Activation of initiator caspases through a stable dimeric intermediate. J Biol Chem 277: 50761-50767
10. Donepudi M, Sweeney AM, Briand C, Grutter MG (2003) Insights into the regulatory mechanism for caspase-8 activation. Mol Cell 11: 543-549
11. Boatright KM, Renatus M, Scott FL, Sperandio S, Shin H, Pedersen IM, Ricci JE, Edris WA, Sutherlin DP, Green DR et al (2003) A unified model for apical caspase activation. Mol Cell 11: 529-541
12. Wang X (2001) The expanding role of mitochondria in apoptosis. Genes Dev 15: 2922-2933
13. Shiozaki EN, Chai J, Rigotti DJ, Riedl SJ, Srinivasula SM, Alnemri ES, Fairman R, Shi Y (2003) Mechanism of XIAP-mediated inhibition of caspase-9. Mol Cell 11: 519-527
14. Joazeiro CA, Weissman AM (2000) RING finger proteins: Mediators of ubiquitin ligase activity. Cell 102: 549-552
15. Verhagen AM, Ekert PG, Pakusch M, Silke J, Connolly LM, Reid GE, Moritz RL, Simpson RJ, Vaux DL (2000) Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to an antagonizing IAP proteins. Cell 102: 43-53
16. Du C, Fang M, Li Y, Li L, Wang X (2000) Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 102: 33-42
17. Verhagen AM, Silke J, Ekert PG, Pakusch M, Kauffmann H, Connolly LM, Day CL, Tikoo A, Burke R, Wrobel C (2002) HtrA2 promotes cell death through its serine protease activity and its ability to antagonize inhibitor of apoptosis proteins. J Biol Chem 277: 445-454
18. Susin SA, Lorenzo HK, Zamzani N, Marzo I, Snow BE, Brothers GM, Mangion J, Jacotot E, Costantini P, Loeffler M et al (1999) Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 397: 441-446
19. Li LY, Luo X, Wang X (2001) Endonuclease G is an apoptotic DNase when released from mitochondria. Nature 412: 95-99
20. Chandra D, Tang DG (2003) Mitochondrially localized active caspase-9 and caspase-3 result mostly from translocation from the cytosol and partly from caspase-mediated activation in the orgamelle. J Biol Chem 278: 17408-17420
21. Chandra D, Choy G, Deng X, Bhatia B, Daniel P, Tang DG (2004) Association of active caspase 8 with the mitochondrial membrane during apoptosis: Potential roles in cleaving BAP31 and caspase 3 and mediating mitochondrial-endoplasmic reticulum cross talk in etoposide-induced cell death. Mol Cell Biol 24: 6592-6607
22. Qin ZH, Wang Y, Kikly KK, Sapp E, Kegel KB, Aronin N, DiFiglia M (2001) Pro-caspase-8 is predominantly localized in mitochondria and released into cytoplasm upon apoptotic stimulation. J Biol Chem 276: 8079-8086
23. Stegh AH, Barnhart BC, Volkland J, Algeciras-schimnich A, Ke N, Reed JC, Peter ME (2002) Inactivation of caspase-8 on mitochondria of Bcl-xL-expressing MCT7-Fas cells: role for the bifunctional apoptosis regulator protein. J Biol Chem 277: 4351-4360
24. Stegh AH, Hermann H, Lampel S, Weisenberger D, Andra K, Seper M, Wiche G, Krammer PH, Peter ME (2000) Identification of the cytolinker plectin as a major early in vivo substrate for caspase 8 during CD95- and tumor necrosis factor receptor-mediated apoptosis. Mol Cell Biol 20: 5665-5679
25. Zamzami N, Marchetti P, Castedo M, Decaudin D, Macho A, Hirsch T, Susin SA, Petit PX, Mignotte B, Kroemer G (1995) Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J Exp Med 182: 367-377
26. Gross A, McDonnell JM, Korsmeyer SJ (1999) BCL-2 family members and the mitochondria in apoptosis. Genes Dev 13: 1899-1911
27. Degterev A, Boyce M, Yuan J (2001) The channel of death. J Cell Biol 155: 695-697
28. Scorrano L, Korsmeyer SJ (2003) Mechanisms of cytochrome c release by proapoptotic BCL-2 family members. Biochem Biophys Res Commun 304: 437-444
29. Eposti MD, Dive C (2003) Mitochondrial membrane permeabilization by Bax/Bak. Biochem Biophys Res Commun 304: 455-461
30. Curtin JF, Donovan M, Cotter TG (2002) Regulation and measurement of oxidative stress in apoptosis. J Immunol Methods 265: 49-72
31. Li PF, Dietz R, von Harsdorf R (1999) p53 regulates mitochondrial membrane potential through reactive oxygen species and induces cytochrome c-independent apoptosis blocked by Bcl-2. EMBO J 18: 6027-6036
32. Gottlieb E, Van der Heiden MG, Thompson CB (2000) Bcl-x(L) prevents initial decrease in mitochondrial membrane potential and subsequent reactive oxygen species production during tumor necrosis factor alpha-induced apoptosis. Mol Cell Biol 20: 5680-5689
33. Behrend L, Henderson G, Zwacka RM (2003) Reactive oxygen species in oncogenic transformation Biochem Soc Trans 31: 1441-1444
34. Gottlieb RA (2000) Mitochondria: Execution central. FEBS Lett 482: 6-12
35. Li H, Zhu H, Xu CJ, Yuan J (1998) Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94: 491-501
36. Sattler M, Liang H, Nettesheim D, Meadows RP, Harlan JE, Eberstadt M, Yoon HS, Shuker SB, Chang BS, Minn AJ et al (1997) Structure of Bcl-xL-Bak peptide complex: Recognition between regulators of apoptosis. Science 275: 983-986
37. Oltvai ZN, Milliman CL, Korsmeyer SJ (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74: 609-619
38. Matsuyama S, Reed JC (2000) Mitochondria dependent apoptosis and cellular pH damage. Cell Death Diff 7: 1155-1165
39. Yu SP, Canzoniero LM, Choi DW (2001) Ion homeostasis and apoptosis. Curr Opin Cell Biol 13: 405-411
40. Hsu YT, Youle RJ (1997) Nonionic detergents induce dimerization among members of the Bcl-2 family. J Biol Chem 272: 13829-13834
41. Wilson-Annan J, O'Reilly LA, Crawford SA, Hausman G, Beaumont JG, Pharma LP, Chen L, Lackman M, Lithgow, T, Hinds MG et al (2003) Proapoptotic BH3-only proteins trigger membrane integration of prosurvival Bcl-w and neutralize its activity. J Cell Biol 162: 877-888
42. Nakai M, Takeda A, Cleary ML, Endo T (1993) The Bcl-2 protein is inserted into the outer membrane but not into the inner membrane of rat liver mitochondria in vitro. Biochem Biophys Res Commun 196: 233-239
43. Distelhorst CW, Shore GC (2004) Bcl-2 and calcium: controversy beneath the surface. Oncogene 23: 2875-2880
44. Massaad CA, Portier BP, Taglialatela G (2004) Inhibition of transcription factor activity by nuclear compartment-associated Bcl-2. J Biol Chem 279: 54470-54478
45. Robertson LE, Plunkett W, McConnell K, Keating MJ, McDonnell TJ (1996) Expression in chronic lymphocytic leukemia and its correlation with the induction of apoptosis and clinical outcome. Leukemia 10: 456-459
46. Kitada S, Andersen J, Akar S, Zapata JM, Takayama S, Krajewski S, Wang H-G, Zhang X, Bullrich F, Croce CM (1998) Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: correlations with in vitro and in vivo chemoresponses. Blood 91: 3379-3389
47. McDonnell TJ, Beham A, Sarkiss M, Andersen MM, Lo P (1996) Importance of Bcl-2 family in cell death regulation. Experentia 52: 1008-1017
48. Pratesi G, Perego P, Zunino F (2001) Role of Bcl-2 and its post-transcriptional modification in response to antitumor therapy. Biochem Pharmacol 61: 381-386
49. Haldar S, Jena N, Croce CM (1995) Inactivation of Bcl-2 by phosphorylation. Proc Natl Acad Sci USA 92: 4507-4511
50. Haldar S, Chintapalli J, Croce CM (1996) Taxol induces Bcl-2 phosphorylation and death of prostate cancer cells. Cancer Res 56: 1253-1255
51. Ito T, Deng X, Carr B, May WS (1997) Bcl-2 phosphorylation required for its anti-apoptotic function. J Biol Chem 272: 11671-11673
52. Chang BS, Minn AJ, Muchmore SW, Fesik SW, Thompson CB (1997) Identification of a novel regulatory domain in Bcl-X(L) and Bcl-2. EMBO J 16: 968-977
53. Kirsch DG, Doseff A, Chau BN, Lim DS, de Souza-Pinto NC, Hansford R, Kastan MB, Lazebnik YA, Hardwick JM (1999) Caspase-3-dependent cleavage of Bcl-2 promotes release of cytochrome c. J Biol Chem 274: 21155-21161
54. Karin M, Lin A (2002) NF-κB at the crossroads of life and death. Nat Immunol 3: 221-227
55. Lin A, Karin M (2003) NF-κB in cancer: a marked target. Semin Cancer Biol 13: 107-114
56. Micheau O, Lens S, Gaide O, Alevizopoulos K, Tschopp J (2001) NF-κB signals induce the expression of c-FLIP. Mol Cell Biol 21: 5299-5305
57. Deveraux QL, Roy N, Stennicke HR, Van Arsdale T, Zhou Q, Srinivasula SM, Alnemri ES, Salvesen GS, Reed JC (1998) IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J 17: 2215-2223
58. Baldwin AS Jr (1996) The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol 14: 649-683
59. Levkau B, Scatena M, Giachelli CM, Ross R, Raines EW (1999) Apoptosis overrides survival signals through a caspase-mediated dominant-negative NF-kappa B loop. Nat Cell Biol 1: 227-233
60. Reuther JY, Baldwin AS Jr (1999) Apoptosis promotes a caspase-induced amino-terminal truncation of IkappaBalpha that functions as a stable inhibitor of NF-kappaB. J Biol Chem 274: 20664-20670
61. Tang G, Yang J, Minemoto Y, Lin A (2001) Blocking caspase-3-mediated proteolysis of IKKbeta suppresses TNF-alpha-induced apoptosis. Mol Cell 8: 1005-1016
62. Hong SY, Yoon WH, Park JH, Kang SG, Ahn JH, Lee TH (2000) Involvement of two NF-kappa B binding elements in tumor necrosis factor alpha -, CD40-, and epstein-barr virus latent membrane protein 1-mediated induction of the cellular inhibitor of apoptosis protein 2 gene. J Biol Chem 275: 18022-18028
63. Arch RH, Gedrich RW, Thompson CB (2000) Translocation of TRAF proteins regulates apoptotic threshold of cells. Biochem Biophys Res Commun 272: 936-945
64. Datta SR, Brunet A, Greenberg ME (1999) Cellular survival: a play in three Akts. Genes Dev 13: 2905-2927
65. Hill MM, Hemmings BA (2002) Inhibition of protein kinase B/Akt. implications for cancer therapy. Pharmacol Ther 93: 243-251
66. Vivanco I, Sawyers CL (2002) The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer 2: 489-501
67. Troussard AA, Mawji NM, Ong C, Mui A, St-Arnaud R, Dedhar S (2003) Conditional knock-out of integrin-linked kinase demonstrates an essential role in protein kinase B/Akt activation. J Biol Chem 278: 22374-22378
68. Damen JE, Liu L, Rosten P, Humphries RK, Jefferson AB, Majerus PW, Krystal G (1996) The 145-kDa protein induced to associate with She by multiple cytokines is an inositol tetraphosphate and phosphatidylinositol 3,4,5-triphosphate 5-phosphatase. Proc Natl Acad Sci USA 93: 1689-1693
69. Stambolic V, Suzuki A, de la Pompa JL, Brothers GM, Mirtsos C, Sasaki T, Ruland I, Penninger JM, Siderovski DP, Mak TW (1998) Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 95: 29-39
70. Wisniewski D, Strife A, Swenseman S, Erdjument-Bromage H, Geromanos S, Kavanaugh WM, Tempst P, Clarkson B (1999) A novel SH2-containing phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase (SHIP2) is constitutively tyrosine phosphorylated and associated with src homologous and collagen gene (SHC) in chronic myelogenous leukemia progenitor cells. Blood 93: 2707-2720
71. Andjelkovic M, Maira S-M, Cron P, Parker PJ, Hemmings BA (1999) Domain swapping used to investigate the mechanism of protein kinase B regulation by 3-phosphoinositide-dependent protein kinase 1 and Ser473 kinase. Mol Cell Biol 19: 5061-5072
72. Maira SM, Galetic I, Brazil DP, Kaech S, Ingley E, Thelen M, Hemmings BA (2001) Carboxyl-terminal modulator protein (CTMP), a negative regulator of PKB/Akt and v-Akt at the plasma membrane. Science 294: 374-380
73. Sato S, Fujita N, Tsuruo T (2000) Modulation of Akt kinase activity by binding to Hsp90. Proc Natl Acad Sci USA 97: 10832-10837
74. Fujita N, Sato S, Ishida A, Tsuruo T (2002) Involvement of Hsp90 in signaling and stability of 3-phosphoinositide-dependent kinase-1. J Biol Chem 277: 10346-10353
75. Hermeking H (2003) The 14-3-3 cancer connection. Nat Rev Cancer 3: 942-943
76. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J, Greenberg ME (1999) Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96: 857-868
77. Cardone MH, Roy N, Stennicke HR, Salvesen GS, Franke TF, Stanbridge E, Frisch S, Reed JC (1998) Regulation of cell death protease caspase-9 by phosphorylation. Science 282: 1318-3121
78. Sordet O, Khan Q, Kohn KW, Pommier Y (2003) Apoptosis induced by topoisomerase inhibitors. Curr Med Chem Anticancer Agents 3: 271-290
79. Ozes ON, Mayo LD, Gustin JA, Pfeffer SR, Pfeffer LM, Donner DB (1999) NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 401: 82-85
80. Romashkova JA, Makarov SS (1999) NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling. Nature 401: 86-90
81. Chang F, Steelman LS, Shelton JG, Lee JT, Navolanic PM, Blalock WL, Franklin R, McCubrey JA (2003) Regulation of cell cycle progression and apoptosis by the Ras/Raf/ERK pathway. Int J Oncol 22: 469-480
82. Lowenstein EJ, Daly RJ, Batzer AG, Li W, Margolis B, Lammers R, Ullrich A, Skolnik EY, Bar-Sagi D, Schlessinger J (1992) The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling. Cell 70: 431-442
83. Chardin P, Camonis JH, Gale NW, van Aelst L, Schlessninger J, Wigler MH, Bar-Sagi D (1993) Human SOS1: a guanine nucleotide exchange factor for Ras that binds to GRB2. Science 260: 1338-1343
84. Xia Z, Dickens M, Raingeaurd J, Davis RJ, Greenberg ME (1995) Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270: 1326-1331
85. Seger R, Krebs EG (1995) The MAPK signaling cascade. FASEB J 9: 726-735
86. Tibbles LA and Woodgett JR (1999) The stress-activated protein kinase pathways. Cell Mol Life Sci 55: 1230-1254
87. Widmann C, Gibson S, Jarpe MB, Johnson GL (1999) Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol Rev 79: 143-180
88. Chang L, Karin M (2001) Mammalian MAP kinase signalling cascades. Nature 410: 37-40
89. Johnson GL, Lapadat R (2002) Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298: 1911-1912
90. Dent P, Yacoub A, Fisher PB, Hagan MP, Grant S (2003) MAPK pathways in radiation responses. Oncogene 22: 5885-5896
91. Wada T, Penninger JM (2004) Mitogen-activated protein kinases in apoptosis regulation. Oncogene 23: 2838-2849
92. Harada H, Quearry B, Ruiz-Vela A, Korsmeyer SJ (2004) Survival factor-induced extracellular signal-regulated kinase phosphorylates BIM, inhibiting its association with BAX and proapoptotic activity. Proc Natl Acad Sci USA 101: 15313-15317
93. Marani M, Hancock D, Lopes R, Tenev T, Downward J, Lemoine NR (2004). Role of Bim in the survival pathway induced by Raf in epithelial cells. Oncogene 23: 2431-2441
94. Wang P, Gilmore AP, Streuli CH (2004) Bim is an apoptosis sensor that responds to loss of survival signals delivered by epidermal growth factor but not those provided by integrins. J Biol Chem 279: 41280-41285
95. Chalmers CJ, Balmanno K, Hadfield K, Ley R, Cook SJ (2003) Thrombin inhibits Bim (Bcl-2-interacting mediator of cell death) expression and prevents serum-withdrawal-induced apoptosis via protease-activated receptor 1. Biochem J 375: 99-109
96. Reginato MJ, Mills KR, Paulus JK, Lynch DK, Sgroi DC, Debnath J, Muthuswamy SK, Brugge JS (2003) Integrins and EGFR coordinately regulate the pro-apoptotic protein Bim to prevent anoikis. Nat Cell Biol 5: 733-740
97. Molton SA, Todd DE, Cook SJ (2003) Selective activation of the c-Jun N-terminal kinase (JNK) pathway fails to elicit Bax activation or apoptosis unless the phosphoinositide 3′-kinase (PI3K) pathway is inhibited. Oncogene 22: 4690-4701
98. Ley R, Balmanno K, Hadfield K, Weston C, Cook SJ (2003) Activation of the ERK1/2 signaling pathway promotes phosphorylation and proteasome-dependent degradation of the BH3-only protein, Bim. J Biol Chem 278: 18811-18816
99. Weston CR, Balmanno K, Chalmers C, Hadfield K, Molton SA, Ley R, Wagner EF, Cook SJ (2003) Activation of ERK1/2 by deltaRaf-1:ER* represses Bim expression independently of the JNK or PI3K pathways. Oncogene 22: 1281-1293
100. Joshi B, Li L, Taffe BG, Zhu Z, Wahl S, Tian H-S, Ben-Josef E, Taylor JD, Porter AT, Tang DG (1999) Apoptosis induction by a novel anti-prostate cancer compound, BMD188 (a fatty acid-containing hydroxamic acid), requires the mitochondrial respiratory chain. Cancer Res 59: 4343-4355
101. Chandra D, Liu JW, Tang DG (2002) Early mitochondrial activation and cytochrome c up-regulation during apoptosis. J Biol Chem 277: 50842-50854
102. Liu J-W, Chandra D, Rudd MD, Butler AP, Pallotta V, Brown D, Coffer PJ, Tang DG (2005) Induction of pro-survival molecules by apoptotic stimuli: Involvement of FOXO3a and ROS. Oncogene 24: 2020-2031
103. Martin AG, Fearnhead HO (2002) Apocytochrome c blocks caspase-9 activation and Bax-induced apoptosis. J Biol Chem 277: 50834-50841
104. 2 in mitochondria. J Biol Chem 278: 2356-2360
105. Martin AG, Nguyen J, Wells JA, Fearnhead HO (2004) Apo cytochrome c inhibits caspases by preventing apoptosome formation. Biochem Biophys Res Commun 319: 944-950
106. Dong Z, Wang J (2004) Hypoxia selection of death-resistant cells: A role for Bcl-xL. J Biol Chem 279: 9215-9221
107. Nijhawan D, Fang M, Traer E, Zhong Q, Gao W, Du F, Wang X (2003) Elimination of Mcl-1 is required for the initiation of apoptosis following ultraviolet irradiation. Genes Dev 17: 1475-1486
108. Sherrill KW, Byrd MP, Van Eden ME, Lloyd RE (2004) BCL-2 translation is mediated via internal ribosome entry during cell stress. J Biol Chem 279: 29066-29074
109. Bachelor MA, Bowden TG (2004) Ultraviolet A-induced modulation of Bcl-XL by p38 MAPK in Human Keratinocytes. Post-transcriptional regulation through the 3′-untranslated region. J Biol Chem 279: 42658-42668
110. Kinnula VL, Crapo JD (2003) Superoxide dismutases in the lung and human lung diseases. Am J Respir Crit Care Med 167: 1600-1619
111. Mikkelsen RB, Wardman P (2003) Biological chemistry of reactive oxygen and nitrogen and radiation-induced signal transduction mechanisms. Oncogene 22: 5734-5754
112. Chen J-G, Yang C-PH, Cammer M, Horwitz SB (2003) Gene expression and mitotic exit induced by microtubule-stabilizing drugs. Cancer Res 63: 7891-7899
113. Takayama S, Reed JC, Homma S (2003) Heat-shock proteins as regulators of apoptosis. Oncogene 22: 9041-9047
114. Parcellier A, Schmitt E, Gurbuxani S, Seigneurin-Berny D, Pance A, Chantome A, Plenchette S, Khochbin S, Solary E, Garrido C (2003) HSP27 is a ubiquitin-binding protein involved in I-kappaBalpha proteasomal degradation. Mol Cell Biol 23: 5790-5802
115. Garrido C, Solary E (2003) A role of HSPs in apoptosis through "protein triage"? Cell Death Differ 10: 619-620
116. Shc localizes to mitochondria where it associates with mitochondrial heat shock protein 70 and regulates transmembrane potential. J Biol Chem 279: 25689-25695
117. Zhang L, Pelech S, Uitto V-J (2004) Bacterial Gro-EL heat shock protein 60 protects epithelial cells from stress-induced death through activation of ERK and inhibition of caspase 3. Exp Cell Res 292: 231-240
118. Green DR, Evan GI (2001). A matter of life and death. Cancer Cell 1: 19-30
119. Shibue T, Takeda K, Oda E, Tanaka H, Murasawa H, Takaoka A, Morishita Y, Akira S, Taniguchi T, Tanaka N (2003) Integral role of Noxa in p53-mediated apoptotic response. Genes Dev 17: 2233-2238
120. Yu J, Wang Z, Kinzler KW, Vogelstein B, Zhang L (2003) PUMA mediates the apoptotic response to p53 in colorectal cancer cells. Proc Natl Acad Sci USA 100: 1931-1936
121. Mahyar-Roemer M, Roemer K (2001) p21 Waf/Cip1 can protect human colon carcinoma cells against p53-dependent and p53-independent apoptosis induced by natural chemopreventive and therapeutic agents. Oncogene 20: 3387-3398
122. ARF and p53 levels and alteration of the Bax/Bcl-2 ratio. J Biol Chem 277: 37949-37954
123. Spierings GE, de Vries E, Stel AJ, Riestap NT, Vellenga E, de Jong S (2004) Low p21waf1/Cip1 protein level sensitizes testicular germ cell tumor cells to Fas-mediated apoptosis. Oncogene 23: 4862-4872
124. Lu PD, Jousse C, Marciniak SJ, Zhang Y, Novoa I, Scheuner D, Kaufman RJ, Ron D, Harding HP (2004) Cytoprotection by pre-emptive conditional phosphorylation of translation initiation factor 2. EMBO J 23: 169-179
125. Donze O, Deng J, Curran J, Sladek R, Picard D, Sonerberg N (2004) The protein kinase PKR: a molecular clock that sequentially activates survival and death programs. EMBO J 23: 564-571
126. Fujioka S, Schmidt C, Sclabas GM, Li Z, Lelicano H, Peng B, Yao A, Niu J, Zhang W, Evans DB et al (2004) Stabilization of p53 is a novel mechanism for proapoptotic function of NF-κB. J Biol Chem 279: 27549-27559
127. Campbell KJ, Rocha S, Perkins ND (2004) Active repression of antiapoptotic gene expression by RelA(p65) NF-κB. Mol Cell 13: 853-865
128. Zamora M, Merono C, Vinas O, Mampel T (2004) Recruitment of NF-κB into mitochondria is involved in adenine nucleotide translocase 1 (ANT1)-induced apoptosis. J Biol Chem 279: 38415-38423
129. Tergaonkar V, Pando M, Vafa O, Wahl G, Verma I (2002) p53 stabilization is decreased upon NFκB activation: a role for NFκB in acquisition of resistance to chemotherapy. Cancer Cell 1: 493-503
130. Jang J-H, Surh Y-J (2004) Bcl-2 attenuation of oxidative cell death is associated with up-regulation of γ-glutamylcysteine ligase via constitutive NF-κB activation. J Biol Chem 279: 38779-38786
131. Mabuchi S, Ohmichi M, Nishio Y, Hayasaka T, Kimura A, Ohta T, Saito M, Kawagoe J, Takahashi K, Yada-Hashimoto N et al (2004) Inhibition of NFκB increases the efficacy of cisplatin in in vitro and in vivo ovarian cancer models. J Biol Chem 279: 23477-23485
132. Balkwill F, Coussens LM (2004) Cancer: an inflammatory link. Nature 431: 405-406
133. Pikarsky E, Porat RM, Stein I, Abramovitch R, Amit S, Kasem S, Gutkovich-Pyest E, Urieli-Shoval S, Galun E, Ben-Neriah Y (2004) NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature 431: 461-466
134. Clevers H (2004) At the crossroads of inflammation and cancer. Cell 118: 671-674
135. Luo JL, Maeda S, Hsu LC, Yagita H, Karin M (2004) Inhibition of NF-kappaB in cancer cells converts inflammation-induced tumor growth mediated by TNFalpha to TRAIL-mediated tumor regression. Cancer Cell 6: 297-305
136. Aggarwal BB (2004) Nuclear factor-kappaB: the enemy within. Cancer Cell 6: 203-208
137. Legembre P, Schickel R, Barnhart BC, Peter ME (2004) Identification of SNF1/AMP kinase-related kinase as an NF-B-regulated anti-apoptotic kinase involved in CD95-induced motility and invasiveness. J Biol Chem 279: 46742-46747
138. Pham CG, Bubici C, Zazzeroni F, Papa S, Jones J, Alvarez K, Jayawardena S, De Smaele E, Cong R, Beaumont C et al (2004) Ferritin heavy chain upregulation by NF-B inhibits TNF-induced apoptosis by suppressing reactive oxygen species. Cell 119: 529-542
139. Algeciras-Schmnich A, Pietras EM, Barnhart BC, Legembre P, Vijayan S, Holbeck SL, Peter ME (2003) Two CD95 tumor classes with different sensitivities to antitumor drugs. Proc Natl Acad Sci USA 100: 11445-11450
140. Micheau O, Tschopp J (2003) Induction of TNF receptor 1-mediated apoptosis via two sequential signaling complexes. Cell 114: 181-190
141. Ehrhardt H, Fulda S, Schmid I, Hiscott J, Debatin K-M, Jeremias I (2003) TRAIL induced survival and proliferation in cancer cells resistant towards TRAIL-induced apoptosis mediated by NF-κB. Oncogene 22: 3842-3852
142. Huerta-Yepez S, Vega M, Jazirehi A, Garban H, Hongo F, Cheng G, Bonaivida B (2004) Nitric oxide sensitizes prostate carcinoma cell lines to TRAIL-mediated apoptosis via inactivation of NF-κB and inhibition of Bcl-xL expression. Oncogene 23: 4993-5003
143. Kreuz S, Siegmund D, Rumpf J-J, Samel D, Leverkus M, Janssen O, Hacker G, Dittrich-Breiholz O, Kracht M, Scheurich P et al (2004) NF-κB activation by Fas is mediated through FADD, caspase-8, and RIP and is inhibited by FLIP. J Cell Biol 166: 369-380
144. Imamura R, Konaka K, Matsumoto N, Hasegawa M, Fukui M, Mukaida N, Kinoshita T, Suda T (2004) Fas ligand induces cell-autonomous NF-κB activation and interleukin-8 production by a mechanism distinct from that of tumor necrosis factor-α. J Biol Chem 279: 46415-46423
145. Barnhart BC, Legenbre P, Pietras E, Bubici C, Franzoso G, Peter ME (2004) CD95 ligand induces motility and invasiveness of apoptosis-resistant tumor cells. EMBO J 23: 3175-3185
146. Danial NN, Gramm CF, Scorrano L, Zhang CY, Kraus S, Ranger AM, Datta SR, Greenberg ME, Licklider LJ, Lowell BB et al (2003) BAD and glucokinase reside in a mitochondrial complex that integrates glycolysis and apoptosis. Nature 424: 952-956
147. Seo SY, Chen Y, Ivanovska I, Ranger AM, Hong SJ, Dwason VL, Korsmeyer SJ, Bellows DS, Fannjiang Y, Hardwick JM (2004) BAD is a pro-survival factor prior to activation of its proapoptotic function. J Biol Chem 279: 42240-42249
148. Nakajima K, Hirose H, Taniguchi M, Kurashina H, Arasaki K, Nagahama M, Tani K, Yamamoto A, Tagaya M (2004) Involvement of BNIP1 in apoptosis and endoplasmic reticulum membrane fusion. EMBO J 23: 3216-3226
149. Jones JM, Datta P, Srinivasula SM, Ji W, Gupta S, Zhang Z, Davies E, Hajnoczky G, Saunders TL, Van Keuren ML et al (2003) Loss of Omi mitochondrial protease activity causes the neuromuscular disorder of mnd2 mutant mice. Nature 425: 721-727
150. Cheng EH-Y, Sheiko TV, Fisher JK, Craigen WJ, Korsmeyer SJ (2003) VDAC2 inhibits BAK activation and mitochondrial apoptosis. Science 301: 513-517
151. Fannjiang Y, Kim CH, Huganir RL, Zou S, Lindsten T, Thompson CB, Mito T, Traystman RJ, Larsen T, Griffin DE et al (2003) BAK alters neuronal excitability and can switch from anti- to pro-death function during postnatal development. Dev Cell 4: 575-585
152. Yang L, Cao Z, Yan H, Wood WC (2003) Coexistence of high levels of apoptotic signaling and inhibitor of apoptosis proteins in human tumor cells: implication for cancer specific therapy. Cancer Res 63: 6815-6824
153. Newton K, Strasser A (2003) Caspases signal not only apoptosis but also antigen-induced activation in cells of the immune system. Genes Dev 17: 819-825
154. Birkenkamp KU, Coffer PJ (2003) FOXO transcription factors as regulators of immune homeostasis: Molecules to die for? J Immunol 171: 1623-1629
155. El-Deiry W (2003) The role of p53 in chemosensitivity and radisensitivity. Oncogene 22: 7486-7495
156. Fridman JS, Lowe SW (2003) Control of apoptosis by p53. Oncogene 22: 9030-9040
157. Chau BN, Wang YJ (2003) Coordinated regulation of life and death by RB. Nat Rev Cancer 3: 130-138
158. Bell LA, Ryan KM (2003) Life and death decisions by E2F-1. Cell Death Differ 10: 1-6
159. Dhakshinamoorthy S, Porter AG (2004) Nitric oxide-induced transcriptional up-regulation of protective genes by Nrf2 via the antioxidant response element counteracts apoptosis of neuroblastoma cells. J Biol Chem 279: 20096-20107
160. Cullinan SB, Diehl JA (2004) ERK-dependent activation of Nrf2 contributes to redox homeostasis and cell survival following endoplasmic reticulum stress. J Biol Chem 279: 20108-20117
161. You H, Jang Y, You-Ten AI, Okada H, Liepa J, Wakeham A, Zaugg K, Mak TW (2004) p53-dependent inhibition of FKHRL1 in response to DNA damage through protein kinase SGK1. Proc Natl Acad Sci USA 101: 14057-14062
162. Hu MC, Lee DF, Xia W, Golfman LS, Ou-Yang F, Yang JY, Zou Y, Bao S, Hanada N, Saso H et al (2004) IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a. Cell 117: 225-237
163. Lin L, Hron JD, Peng SL (2004) Regulation of NF-kappaB, Th activation, and autoinflammation by the forkhead transcription factor Foxo3a. Immunity 21: 203-213
164. Huang H-L, Fang L-W, Lu S-P, Chou C-K, Luh T-Y, Lai M-Z (2003) DNA-damaging reagents induce apoptosis through reactive oxygen species-dependent Fas aggregation. Oncogene 22: 8168-8177
165. Katoh I, Tomimori Y, Ikawa Y, Kurata S (2004) Dimerization and processing of procaspase-9 by redox stress in mitochondria. J Biol Chem 279: 15515-15523
166. Sattler M, Winkler T, Verma S, Byrne CH, Shrikhande G, Salgia R, Griffin JD (1999) Hematopoietic growth factors signal through the formation of reactive oxygen species. Blood 93: 2928-2935
167. 2 for platelet-derived growth factor signal transduction. Science 270: 296-299
168. Vaquero EC, Edderkaoui M, Pandol SJ, Gukovsky I, Gukovskaya AS (2004) Reactive oxygen species produced by NAD(P)H oxidase inhibit apoptosis in pancreatic cancer cells. J Biol Chem 279: 34643-34654
169. 2-M checkpoint in response to oxidative stress. J Biol Chem 277: 26729-26732
170. Kops GJPL, Dansen TB, Polderman PE, Saarloos I, Wirtz KWA, Coffer PJ, Huang T-T, Bos JL, Medema RH, Burgering BMT (2002) Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress. Nature 419: 316-321
171. Nemoto S, Finkel T (2002) Redox regulation of forkhead proteins through a p66shc-dependent signaling pathway. Science 295: 2450-2452
172. Brunet A, Sweeney LB, Sturgill JF, Chua KF, Greer PL, Lin Y, Tran H, Ross SE, Mostoslavsky R, Cohen HY et al (2004) Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 303: 2011-2015
173. Macip S, Igarashi M, Berggren P, Yu J, Lee SW, Aaronson SA (2003) Influence of induced reactive oxygen species in p53-mediated cell fate decisions. Mol Cell Biol 23: 8576-8585
174. McCormick F (2004) Survival pathways meet their ends. Nature 428: 267-269
175. Wendel H-G, de Stanchina E, Fridman JS, Malina A, Ray S, Kogan S, Cordon-Cardo C, Pelletier J, Lowe SW (2004) Survival signaling by Akt and eIF4E in oncogenesis and cancer therapy. Nature 428: 332-337